PHASE II TRIAL OF 131I-CC49 Mab PLUS ALPHA INTERFERON (rIFNα) IN BREAST CANCER

• 1 August 1994
• journal article
• Published by Wolters Kluwer Health in Journal of Immunotherapy
• Vol. 16  (2) , 162
• https://doi.org/10.1097/00002371-199408000-00066

Abstract

Keywords

• BREAST CANCER